Health Ministry approves phase 3 clinical trial of Nanocovax vaccine
(VOVWORLD) -Deputy Minister of Health Tran Van Thuan has just signed a decision approving the phase 3 clinical trial project of Nanocovax vaccine developed by the Ho Chi Minh City-based Nanogen Company. Nanocovax is Vietnam's first Covid-19 vaccine officially entering phase 3 human trial, which will test the vaccine for about 13,000 volunteers.
 Preparing for the 3rd phase of Nanocovax vaccination for volunteers at the Military Medical Academy, June 10. Photo: Ngoc Thanh/VNExpress
|
At the Military Medical Academy, more than 6,000 volunteers have registered to participate in the trial, of which more than 600 will be screened to be eligible to get the shots. Initially, the Academy will test the Nanocovax vaccine for 1,000 volunteers, divided into 2 groups, one group will be injected a dose of 25mcg and the other group to be injected a placebo to compare the protective efficacy of the vaccine.
Lieutenant General Do Quyet, Director of the Military Medical Academy said early this month that volunteers will be monitored for 42 days to evaluate the vaccine’s safety and effectiveness against the coronavirus.
If the pandemic persists, the Academy will seek approval from the Medical Ethics Council of the Ministry of Health for emergency use and will continue our evaluation afterwards. If approved, the vaccine will be administered in September, said Quyet.